KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Short term Debt (2020 - 2025)

Historic Short term Debt for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $28.5 million.

  • Fulgent Genetics' Short term Debt rose 593.06% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 593.06%. This contributed to the annual value of $27.6 million for FY2024, which is 2163.0% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Short term Debt is $28.5 million, which was up 593.06% from $27.6 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Short term Debt peaked at $45.3 million during Q2 2021, and registered a low of $14.5 million during Q2 2023.
  • Moreover, its 5-year median value for Short term Debt was $26.3 million (2024), whereas its average is $25.0 million.
  • As far as peak fluctuations go, Fulgent Genetics' Short term Debt plummeted by 5006.73% in 2023, and later surged by 8186.03% in 2024.
  • Fulgent Genetics' Short term Debt (Quarter) stood at $19.8 million in 2021, then dropped by 24.27% to $15.0 million in 2022, then surged by 51.34% to $22.7 million in 2023, then rose by 21.63% to $27.6 million in 2024, then rose by 3.38% to $28.5 million in 2025.
  • Its Short term Debt stands at $28.5 million for Q3 2025, versus $27.6 million for Q2 2025 and $27.7 million for Q1 2025.